Quantcast
Channel: BioTuesdays » Dr. Juan Sanchez
Browsing latest articles
Browse All 4 View Live

Image may be NSFW.
Clik here to view.

Ladenburg maintains Ironwood at buy after Synergy results

Ladenburg Thalmann has maintained its “buy” rating and $16 price target on Ironwood Pharmaceuticals (NASDAQ:IRWD) after Synergy Pharmaceuticals (NASDAQ:SGYP) announced results from the plecanatide...

View Article



Image may be NSFW.
Clik here to view.

Ladenburg ups Ironwood target to $18

Ladenburg Thalmann has raised its price target on “buy-rated” Ironwood Pharmaceuticals (NASDAQ:IRWD) to $18 from $16, saying that until recently three factors had depressed the company’s valuation....

View Article

Image may be NSFW.
Clik here to view.

Addex announces plans to list in U.S.

Swiss-based Addex Therapeutics (SIX:ADXN) has announced plans to list on a U.S. stock exchange as part of several strategic changes, including a focus on rare diseases with at least two programs in the...

View Article

Image may be NSFW.
Clik here to view.

Ladenburg starts Tetraphase at buy

Ladenburg Thalmann has initiated coverage Tetraphase Pharmaceuticals (NASDAQ:TTPH) with a “buy” rating at price target of $13. The stock closed at $8.42 on Tuesday. Tetraphase’s lead product,...

View Article
Browsing latest articles
Browse All 4 View Live




Latest Images